About: Hepatitis C Screening in Community-Based Voluntary Counselling and Testing Services in Europe: An Observational Study from the COBATEST Network 2014

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hepatitis C Screening in Community-Based Voluntary Counselling and Testing Services in Europe: An Observational Study from the COBATEST Network 2014–2018 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Hepatitis C Screening in Community-Based Voluntary Counselling and Testing Services in Europe: An Observational Study from the COBATEST Network 2014–2018
Creator	Casabona, Jordi Cobatest Study Group, · Conway, Anna Fernàndez-López, Laura Reyes-Urueña, Juliana
Source	PMC
abstract	The COBATEST Network links community-based voluntary counselling and testing (CBVCT) services in the European region and collects testing data using standardised data collection tools. This study aims to describe the population being screened for anti-HCV antibodies in the COBATEST Network and identify risk factors associated with a reactive HCV screening test result in the period 2014–2018. Clients aged > 16 screened for HCV in the period 2014–2018 at one of the Network’s CBVCT services were included in the study. In the 5 year period, 7426 clients were screened for HCV in 22 centres in 10 countries and anti-HCV antibodies were detected in 113 (1.5%). The majority of people screened were aged 25–44, men who have sex with men (MSM), not HIV+ , not reporting a history of injecting drug use or sex work. Detection of anti-HCV antibodies was associated with being HIV + MSM (aOR 9.1, 95% CI 3.8; 21.8 compared to HIV-clients) and being a person who injects drugs (PWID, aOR 28.1, 95% CI 17.6; 45.0, compared to people with no history of injecting drug use). This study demonstrates that HIV-MSM with no history of injection drug use are using CBVCT services for HCV screening, but reactive screening test is associated with being HIV+ or PWID. The integration of HCV screening into the CBVCT service model may widen access to testing for populations that may otherwise not be tested. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10900-019-00780-0) contains supplementary material, which is available to authorized users.
has issue date	2019-11-20(xsd:dateTime)
bibo:doi	10.1007/s10900-019-00780-0
bibo:pmid	31749115
has license	no-cc
sha1sum (hex)	e7fc563ade693349129e93032e47aa25e87ba864
schema:url	https://doi.org/10.1007/s10900-019-00780-0
resource representing a document's title	Hepatitis C Screening in Community-Based Voluntary Counselling and Testing Services in Europe: An Observational Study from the COBATEST Network 2014–2018
has PubMed Central identifier	PMC7095007
has PubMed identifier	31749115
schema:publication	J Community Health
resource representing a document's body	covid:e7fc563ade693349129e93032e47aa25e87ba864#body_text
is schema:about of	named entity 'drug' named entity 'counselling' named entity 'reactive' named entity 'antibodies' named entity 'ACCESS' named entity '2018' named entity 'CLIENTS' named entity 'COMMUNITY' named entity 'DRUGS' covid:arg/e7fc563ade693349129e93032e47aa25e87ba864 named entity 'HIV' named entity 'MSM' named entity 'HCV' named entity 'injecting' named entity '2018' named entity 'Network' named entity 'HIV' named entity 'screening test' named entity 'service model' named entity 'HCV' named entity 'antibodies' named entity 'HIV+' named entity 'antibodies' named entity '3.8' named entity 'HIV' named entity 'HCV' named entity 'Journal of Community Health' named entity 'screening test' named entity 'compared' named entity 'HCV' named entity 'missing data' named entity 'morbidity' named entity 'HCV' named entity 'HCV' named entity 'HCV' named entity 'HCV' named entity 'MSM' named entity 'essential element' named entity 'HCV' named entity 'antibodies' named entity 'HCV' named entity 'epidemiological' named entity 'screening test' named entity 'general population' named entity 'WHO' named entity 'World Health Organization' named entity 'HIV testing' named entity 'randomly assigned' named entity 'HCV' named entity 'HCV' named entity 'HCV' named entity 'risk assessment' named entity 'RNA' named entity 'HIV' named entity 'HIV' named entity 'missing data' named entity 'STI' named entity 'HCV' named entity 'public health' named entity 'Data analysis' named entity 'HIV+' named entity 'HCV' named entity 'sex work' named entity 'HIV' named entity 'HCV' named entity 'database' named entity 'prophylaxis' named entity 'HIV test' named entity 'HCV' named entity 'statistically significant' named entity 'Survey Monkey' named entity 'HCV' named entity 'database' named entity 'rapid diagnostic test' named entity 'syphilis screening' named entity 'plasma' named entity 'WHO'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software